Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 3
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Vergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function.
Jenewein EC, Cotter S, Roberts T, Kulp M, Mitchell GL, Jones-Jordan LA, Chen AM, Hopkins K, Huang K, Amster D, Fecho G, Tyler J, Meiyeppen S, Scheiman M; Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART) Investigator Group. Jenewein EC, et al. Ophthalmic Physiol Opt. 2023 Jan;43(1):105-115. doi: 10.1111/opo.13062. Epub 2022 Oct 22. Ophthalmic Physiol Opt. 2023. PMID: 36271753 Free PMC article.
PURPOSE: To evaluate the time course of improvements in clinical convergence measures for children with symptomatic convergence insufficiency treated with office-based vergence/accommodative therapy. METHODS: We evaluated convergence meas …
PURPOSE: To evaluate the time course of improvements in clinical convergence measures for children with symptomatic converg …
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Kulp MT, Sinnott LT, Cotter SA, Borsting E, Toole AJ, Chen AM, Jenewein EC, Morrison AM, Plaumann MD, Jones-Jordan L, Mitchell GL, Tea YC, Scheiman MM; Convergence Insufficiency Treatment Trial (CITT) Investigator Group; Convergence Insufficiency Treatment Trial - Attention, Reading Trial (CITT-ART) Investigator Group. Kulp MT, et al. Ophthalmic Physiol Opt. 2022 Jan;42(1):59-70. doi: 10.1111/opo.12911. Epub 2021 Nov 3. Ophthalmic Physiol Opt. 2022. PMID: 34730250 Free PMC article.
PURPOSE: To determine whether coexisting accommodative dysfunction in children with symptomatic convergence insufficiency (CI) impacts presenting clinical convergence measures, symptoms and treatment success for CI. METHODS: Secondary data analy …
PURPOSE: To determine whether coexisting accommodative dysfunction in children with symptomatic convergence insufficiency (CI) …
Effectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency.
Chen AM, Roberts TL, Cotter SA, Kulp MT, Sinnott LT, Borsting EJ, Tea YC, Jones-Jordan LA, Hertle R, Mitchell GL, Eugene Arnold L, Chase C, Scheiman MM; Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART) Investigator Group. Chen AM, et al. Ophthalmic Physiol Opt. 2021 Jan;41(1):21-32. doi: 10.1111/opo.12747. Epub 2020 Oct 29. Ophthalmic Physiol Opt. 2021. PMID: 33119180 Free PMC article. Clinical Trial.
METHODS: We report changes in accommodative function following therapy among participants in the Convergence Insufficiency Treatment Trial - Attention and Reading Trial with decreased accommodative amplitude (115 participants in ve …
METHODS: We report changes in accommodative function following therapy among participants in the Convergence Insufficiency …
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Convergence Insufficiency Treatment Trial (CITT) Investigator Group and the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART) Investigator Group. Convergence Insufficiency Treatment Trial (CITT) Investigator Group and the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART) Investigator Group. Ophthalmic Physiol Opt. 2022 Nov;42(6):1412-1413. doi: 10.1111/opo.13052. Epub 2022 Sep 16. Ophthalmic Physiol Opt. 2022. PMID: 36111644 Free PMC article. No abstract available.